JNJ-7777120 was a drug being developed by

Johnson & Johnson Pharmaceutical Research & Development Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) is a subsidiary of Johnson & Johnson that is responsible for drug discovery, discovering and drug development, developing pharmaceutical drugs. J&JPRD has research sites located in ...

which acts as a potent and selective antagonist at the histamine H₄ receptor. It has

anti-inflammatory Anti-inflammatory is the property of a substance or treatment that reduces inflammation or swelling. Anti-inflammatory drugs, also called anti-inflammatories, make up about half of analgesics. These drugs remedy pain by reducing inflammation as o ...

effects, and has been demonstrated to be superior to traditional (H1) antihistamines in the treatment of

pruritus Itch (also known as pruritus) is a sensation that causes the desire or reflex to scratch. Itch has resisted many attempts to be classified as any one type of sensory experience. Itch has many similarities to pain, and while both are unpleasant ...

(itching). The drug was abandoned because of its short ''

in vivo Studies that are ''in vivo'' (Latin for "within the living"; often not italicized in English) are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, and ...

half-life Half-life (symbol ) is the time required for a quantity (of substance) to reduce to half of its initial value. The term is commonly used in nuclear physics to describe how quickly unstable atoms undergo radioactive decay or how long stable at ...

and

hypoadrenocorticism Addison's disease, also known as primary adrenal insufficiency, is a rare long-term endocrine disorder characterized by inadequate production of the steroid hormones cortisol and aldosterone by the two outer layers of the cells of the adrenal ...

toxicity in rats and dogs, that prevented advancing it into clinical studies.

References

Carboxamides Chloroarenes H4 receptor antagonists Indoles Johnson & Johnson brands Piperazines Abandoned drugs {{pharma-stub

See also

References